117 related articles for article (PubMed ID: 9413168)
61. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.
Mershon SM; Anding AL; Chapman JS; Clagett-Dame M; Stonerock LA; Curley RW
Bioorg Med Chem Lett; 2007 Feb; 17(3):836-40. PubMed ID: 17112722
[TBL] [Abstract][Full Text] [Related]
62. Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomas.
Moral R; Solanas M; García G; Colomer R; Escrich E
Oncol Rep; 2003; 10(5):1417-24. PubMed ID: 12883717
[TBL] [Abstract][Full Text] [Related]
63. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.
Perletti G; Concari P; Giardini R; Marras E; Piccinini F; Folkman J; Chen L
Cancer Res; 2000 Apr; 60(7):1793-6. PubMed ID: 10766159
[TBL] [Abstract][Full Text] [Related]
64. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
Hultin TA; Filla MS; McCormick DL
Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
[TBL] [Abstract][Full Text] [Related]
65. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
[TBL] [Abstract][Full Text] [Related]
66. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
67. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Samy RP; Gopalakrishnakone P; Ignacimuthu S
Chem Biol Interact; 2006 Dec; 164(1-2):1-14. PubMed ID: 17064676
[TBL] [Abstract][Full Text] [Related]
68. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model.
Hakkak R; MacLeod S; Shaaf S; Holley AW; Simpson P; Fuchs G; Jo CH; Kieber-Emmons T; Korourian S
Int J Oncol; 2007 Mar; 30(3):557-63. PubMed ID: 17273756
[TBL] [Abstract][Full Text] [Related]
69. Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat.
Gupta A; Nines R; Rodrigo KA; Aziz RA; Carlton PS; Gray DL; Steele VE; Morse MA; Stoner GD
J Natl Cancer Inst; 2001 Jul; 93(13):990-8. PubMed ID: 11438564
[TBL] [Abstract][Full Text] [Related]
70. Change in chemosensitivity of DMBA-induced rat mammary tumor after oophorectomy.
Isogai M; Kondo K; Kitamura N
Anticancer Res; 1998; 18(2A):963-6. PubMed ID: 9615747
[TBL] [Abstract][Full Text] [Related]
71. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats.
Radcliffe JD; Moon RC
Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008
[TBL] [Abstract][Full Text] [Related]
72. Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene.
Rao GN; Ney E; Herbert RA
Breast Cancer Res Treat; 1998 Apr; 48(3):265-71. PubMed ID: 9598873
[TBL] [Abstract][Full Text] [Related]
73. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
McCormick DL; Moon RC
Carcinogenesis; 1986 Feb; 7(2):193-6. PubMed ID: 2936526
[TBL] [Abstract][Full Text] [Related]
74. Clinical development plan: N-(4-hydroxyphenyl)retinamide.
Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
J Cell Biochem Suppl; 1994; 20():176-96. PubMed ID: 7616742
[No Abstract] [Full Text] [Related]
75. Effects of N-(4-hydroxyphenyl)-retinamide on the number and cytotoxicity of natural killer cells in vitamin-A-sufficient and -deficient rats.
Zhao Z; Matsuura T; Popoff K; Ross AC
Nat Immun; 1994; 13(5):280-8. PubMed ID: 7833627
[TBL] [Abstract][Full Text] [Related]
76. Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye.
Lewis KC; Zech LA; Phang JM
Eur J Cancer; 1996 Sep; 32A(10):1803-8. PubMed ID: 8983293
[TBL] [Abstract][Full Text] [Related]
77. Breast cancer and fenretinide, an analogue of vitamin A.
Cobleigh MA
Leukemia; 1994; 8 Suppl 3():S59-63. PubMed ID: 7808027
[TBL] [Abstract][Full Text] [Related]
78. In vivo antitumor activity of tetrahydrobenz(a)anthraquinone derivatives.
Morreal CE; Sinha DK; White CJ
Anticancer Res; 1990; 10(4):935-7. PubMed ID: 2382991
[TBL] [Abstract][Full Text] [Related]
79. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats.
Haraoui B; Wilder RL; Allen JB; Sporn MB; Helfgott RK; Brinckerhoff CE
Int J Immunopharmacol; 1985; 7(6):903-16. PubMed ID: 3000963
[TBL] [Abstract][Full Text] [Related]
80. Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.
Kocdor H; Kocdor MA; Canda T; Gurel D; Cehreli R; Yilmaz O; Alakavuklar M; Guner G
Clin Transl Oncol; 2009 Apr; 11(4):243-9. PubMed ID: 19380302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
